- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 0
- Scientists listed
- 0
- Grants since 2016
- 7
Grants received
2025–2027 · grant · PRMRP
A First-in-Class, Agnostic, Host-Directed Precision Medicine Treatment for Acute Respiratory Distress Syndrome
Martina Buck · Xfibra (United States) · funded by Congressionally Directed Medical Research Programs
2024–2025 · research · R44
An Agnostic, Host-Direct Survival Cure MCM for Pulmonary Toxicants.
Martina Buck · Xfibra (United States) · funded by National Institutes of Health
2020–2024 · grant · PRMRP
Pulmonary Fibrosis: Novel Therapeutic Development
Mario Chojkier · Xfibra (United States) · funded by Congressionally Directed Medical Research Programs
2019–2020 · research · R44
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY
Martina Buck · Xfibra (United States) · funded by National Institutes of Health
2019–2021 · research · R44
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY
Martina Buck · Xfibra (United States) · funded by National Institutes of Health
2019–2020 · research · R44
TREATMENT OF LUNG FIBROSIS : IND PHARMACOLOGY AND TOXICOLOGY
Martina Buck · Xfibra (United States) · funded by National Institutes of Health
2019–2021 · research · R44
TREATMENT OF LUNG FIBROSIS : IND PHARMACOLOGY AND TOXICOLOGY
Martina Buck · Xfibra (United States) · funded by National Institutes of Health